Status:
COMPLETED
STAK Tool for Treatment of Arthrofibrosis Post Total Knee Replacement
Lead Sponsor:
University Hospitals, Leicester
Conditions:
Arthrofibrosis
Eligibility:
All Genders
18-95 years
Phase:
NA
Brief Summary
A common complication following total knee replacement (TKR) is arthrofibrosis, a severe stiffening of the knee caused by scar tissue. The aims of this mixed methods feasibility study are to (1) reco...
Detailed Description
Arthrofibrosis most commonly occurs after total knee replacement (TKR), extensive intra-articular injury or surgical procedures, for example fracture of the proximal tibia or distal femur or multiple ...
Eligibility Criteria
Inclusion
- male or female,
- 18 to 95 year olds,
- having received a primary total knee replacement within the last 12 months.
- Following their TKR have less than 70 degrees knee flexion or have been prescribed intensive physiotherapy for their knee stiffness by their Consultant.
- Between 44kg and 159kg.
Exclusion
- post malignancy or knee trauma
- have leaking wounds or infected joints,
- have rheumatoid arthritis or osteoporosis,
- have undergone long term steroid treatment or the clinician felt the patient was at risk of post-operative fracture.
- Fell outside weight limits (44kg to 159kg),
- Unable to give consent themselves (confusion, non-English speaking patients).
Key Trial Info
Start Date :
August 2 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 19 2019
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT04019847
Start Date
August 2 2017
End Date
August 19 2019
Last Update
April 28 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospitals of Leicester NHS Trust
Leicester, United Kingdom, LE5 4PW